Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1059 | 985 | 1059 | 969 | 1041 | 1155 |
Fund Return | 5.93% | -1.5% | 5.93% | -1.03% | 0.8% | 1.45% |
Place in category | 405 | 461 | 405 | 246 | 278 | 126 |
% in Category | 72 | 80 | 72 | 52 | 70 | 66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 8.01B | 28.87 | 6.79 | - | ||
CH0429081638 | 8.01B | 3.42 | 7.87 | - | ||
CH0337393745 | 6.71B | 27.07 | 6.15 | - | ||
CSIF CH Emerging Markets Index Blue | 3.52B | 15.87 | -2.09 | 2.72 | ||
CH0017844686 | 3.54B | 15.77 | -2.17 | 2.63 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Vitainvest 50 World U | 4.36B | 7.32 | -1.50 | 2.35 | ||
Raiffeisen Pension Invest Futura BI | 4.35B | 6.47 | -2.59 | 1.75 | ||
Raiffeisen Pension Invest Futura Ba | 4.28B | 6.47 | -2.59 | 1.75 | ||
Julius Baer Institutional BVG LPPb1 | 3.88B | 7.67 | 0.30 | 3.34 | ||
Julius Baer Institutional BVG LPPB2 | 3.88B | 7.88 | 0.48 | 3.52 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares MSCI Emerging Markets UCITS Dist | IE00B0M63177 | 6.21 | 3,463.3 | +0.69% | |
Vanguard S&P 500 UCITS USD Inc | IE00B3XXRP09 | 5.39 | 92.49 | -0.14% | |
Nestle | CH0038863350 | 3.36 | 78.10 | +0.77% | |
iShares J.P. Morgan $ Emerging Markets Bond UCITS | IE00B2NPKV68 | 3.05 | 88.96 | -0.08% | |
Novartis | CH0012005267 | 2.44 | 97.21 | -0.51% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review